1. All physiological change is mediated by proteins. 2. Protein function depends on protein shape and shape changes. 3. A series of enzymatic reactions converts tyrosine into the signaling molecules dopamine, norepinephrine, and epinephrine. 4. Muscle contraction and its initiation and cessation depend on the binding specificity and allosteric properties of proteins. 5. Biological membranes are a mosaic of proteins embedded in a phospholipid bilayer. 1. Only small, uncharged molecules and oily molecules can penetrate biomembranes without the aid of proteins. 2. Molecules move spontaneously from regions of high free energy to regions of lower free energy. 3. Important transport equations summarize the contributions of the various driving forces. 4. Starling’s hypothesis relates fluid flow across the capillaries to hydrostatic pressure and osmotic pressure. 5. Membrane proteins that serve the triple functions of selective transport, catalysis, and coupling can pump ions and molecules to regions of higher free energy. 6. Many membrane proteins selectively facilitate the transport of ions/molecules from high to low electrochemical potential. 7. Passive transport of K+ across the plasma membrane creates an electrical potential. 8. Spatial organization of active and passive transport proteins enables material to pass completely through the cell. 9. Membrane fusion allows for a combination of compartmentalization and transport of material. Information transmission and transduction 1. Cell signaling often occurs by a lengthy chain of sequential molecular interactions. 2. Signaling pathways begin with the binding of an extracellular molecule to a receptor. 3. Specific physiological information is inherent in the receptor/ligand complex, not in the hormone/neurotransmitter molecule. 4. G-protein–coupled receptors are the largest family (a superfamily) of receptors and help regulate almost all physiological processes. 5. Most G-protein–linked information is sent to the cytoplasm by second messengers. 6. Ca2+ transport across plasma and intracellular membranes is an important second messenger. 7. Cyclic AMP is produced by activation of a membrane-bound enzyme in response to hormone/neurotransmitter binding to receptors. 8. The receptor-mediated hydrolysis of a rare phospholipid of the plasma membrane produces two different second messengers with different actions. 9. Steroid hormones and other lipid signals interact with nuclear receptors, which are transcription factors within the cell. Allosteric changes in protein conformation arise in four general ways. One way, just mentioned, is that most proteins change shape depending on which ligands are bound at particular binding sites (Figure 1-1, A). The sequence—specific ligand binding → protein shape change → change in protein-binding properties and protein function → this change regulates something—is a common molecular mechanism underlying physiological control. This method involves no alteration in the covalent structure of the protein. A second method of producing conformational change, however, occurs as a result of the covalent modification of one or more of the amino acid side groups of the protein (see Figure 1-1, B). By far the most common such change is the covalent addition of a phosphate group to the hydroxyl (—OH) group on the side chain of serine, threonine, or tyrosine residues in the protein. This modification is called phosphorylation. Because the phosphate group is highly charged, phosphorylation of a protein alters hydrogen bonding and other electrostatic interactions within the protein chain, altering its conformation and functional properties. In a third method, some physiologically important proteins change shape in response to the electrical field surrounding the protein (see Figure 1-1, C). These respond to a voltage change by altering the position of charged amino acids, thus altering protein shape. Step A: ATP binds to a myosin head; in this conformation, myosin has little ability to bind to actin. Step B: Enzymatic activity associated with the myosin head, an adenosinetriphosphatase (ATPase), rapidly causes a partial hydrolysis of ATP to adenosine diphosphate (ADP) and inorganic phosphate (Pi), both of which stay bound to the myosin. With ADP and Pi bound, myosin has a slightly different shape that binds avidly to nearby actin filaments. Step C: When myosin binds to actin, called cross-bridging, the myosin head couples the complete hydrolysis of ATP to a forceful flexing of the myosin head. This allosteric change causes the actin filament to slide past the thick filament. This sliding puts the actin filament under tension, which in turn causes the muscle to contract (shorten) against the load of the muscle (i.e., lifting a weight or pumping out blood). All muscle contraction depends on this sliding filament mechanism of actin and myosin-based filaments. This same allosteric change of myosin also alters myosin-binding properties so that it releases the ADP and Pi. Step D: The binding of a new ATP molecule to the myosin head again causes myosin to change shape; the head unflexes and loses its affinity for actin, releasing the cross-bridge, and the cycle can start over. Rigor mortis of dead animals is caused by a lack of new ATP to bind to myosin heads. In the absence of ATP, myosin heads remain in Step C (i.e., bound to actin). The muscle is stiff because it is completely cross-bridged together. This system of contractile proteins requires some control so that, for example, the heart beats rhythmically and skeletal muscle contraction is coordinated. At the organismal level, skeletal and cardiac muscle contraction is primarily under control by electrical stimulation from nerves or other electrically active cells (see Chapter 6). The transmission of electrical excitation to the actomyosin system is called excitation-contraction coupling. Excitation-contraction coupling in all types of muscle depends on changes in intracellular calcium ion (Ca2+) concentration. In skeletal and cardiac muscle, but not smooth muscle, two additional thin-filament proteins, troponin and tropomyosin, are required for this coupling. (Excitation-contraction coupling for smooth muscle is discussed later in this chapter.) In striated muscles, troponin binds to tropomyosin and to Ca2+. Tropomyosin is a long, thin protein that binds in the groove of the actin filament in such a way that its positions, high in the groove or snuggled down deep in the groove, allow or prevent the myosin head access to the thin filament (Figure 1-5). Excitation-contraction coupling of striated muscle works as follows: Step A: Electrical excitation of a striated muscle cell causes an increase in the intracellular concentration of Ca2+. Step B: The additional Ca2+ binds to troponin, causing an allosteric change in troponin. Step C: Because Ca2+ is bound to troponin, which in turn is bound to tropomyosin, the Ca2+-induced change in troponin conformation is transmitted to the tropomyosin molecule. When troponin binds Ca2+, tropomyosin changes its binding to actin in such a way that it exposes the actin site for myosin cross-bridging. (Tropomyosin snuggles down deeper in its actin groove, revealing actin to the myosin head.) As long as troponin binds Ca2+, the muscle contracts by the actomyosin cycle outlined earlier. Step D: When the Ca2+ concentration drops to normal, however, troponin no longer binds Ca2+. This causes tropomyosin to move up in the thin filament groove so that it again blocks the myosin-binding sites on actin. Myosin heads can no longer cross-bridge, and muscle contraction stops. Charged particles (i.e., ions) do not pass through a pure phospholipid bilayer because of the inner, hydrophobic region of bilayer. Polar molecules (molecules with no net charge but with electrical imbalances) with a molecular weight greater than about 100 daltons are also unable to pass readily through a pure lipid bilayer, thus excluding all sugar molecules (monosaccharides), amino acids, nucleosides, as well as their polymers (polysaccharide, proteins, nucleic acids). On the other hand, some crucially important polar molecules (e.g., water, urea) are small enough to pass through the lipid bilayer. Small, moderate-size, and large molecules that are soluble in oily solvents readily pass through a pure lipid bilayer. Physiologically important molecules in this class include O2, N2, and the steroid hormones (see Chapters 33 and 34). However, many toxic, synthetic molecules, such as insecticides, are also in this category. Π =Osmotic pressure, the driving force for water movement expressed as an equivalent hydrostatic pressure in atmospheres (1 atm = 15.2 lb/in2 = 760 mm Hg). Osmotic pressure is symbolized by Π to distinguish it from other types of pressure terms. i =Number of ions formed by dissociating solutes (e.g., 2 for NaCl, 3 for CaCl2). R =Gas constant = 0.082 L atm/mol degree. T =Temperature on the Kelvin scale; 0° C = 273° K. Δc =Difference in the molar concentration of the impermeable substance across the membrane.
The Molecular and Cellular Bases of Physiological Regulation
Protein Function Depends on Protein Shape and Shape Changes
Muscle Contraction and its Initiation and Cessation Depend on the Binding Specificity and Allosteric Properties of Proteins
Transport
Only Small, Uncharged Molecules and Oily Molecules Can Penetrate Biomembranes Without the Aid of Proteins
Important Transport Equations Summarize the Contributions of the Various Driving Forces
Starling’s Hypothesis Relates Fluid Flow Across the Capillaries to Hydrostatic Pressure and Osmotic Pressure
You may also need
Full access? Get Clinical Tree
The Molecular and Cellular Bases of Physiological Regulation
Only gold members can continue reading. Log In or Register a > to continue